HomeInsightsMarket Capitalization

Market Capitalization of Jenburkt Pharmaceuticals Ltd

Market Capitalization of Jenburkt Pharmaceuticals Ltd

stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

1.9 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

MARKETCAP

500.51 crore

Last updated: 18 Sep 24

Key Highlights

  • The Market Cap of Jenburkt Pharmaceuticals Ltd is ₹ 500.51 crore as of 18 Sep 24.
  • The Market Cap of Jenburkt Pharmaceuticals Ltd changed from ₹ 231.86 crore on March 2019 to ₹ 304.27 crore on March 2024 . This represents a CAGR of 4.63% over 6 years. .
  • The Latest Trading Price of Jenburkt Pharmaceuticals Ltd is ₹ 1134 as of 18 Sep 15:30.

Historical Market Cap of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Jenburkt Pharmaceuticals Ltd

No data available

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

PRICE

1134.1

22.30 (2.01%)

stock direction

Last updated: 18 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 20241134.1
17 Sep 20241111.8
16 Sep 20241128.5
13 Sep 20241120.2
12 Sep 20241127.15
11 Sep 20241133.9
10 Sep 20241189.2
09 Sep 20241144.95
06 Sep 20241144.8
05 Sep 20241182.7

SWOT Analysis Of Jenburkt Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Jenburkt Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Jenburkt Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Jenburkt Pharmaceuticals Ltd

No data available

Historical P/E Ratio of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Jenburkt Pharmaceuticals Ltd

No data available

* All values are in %

About Jenburkt Pharmaceuticals Ltd

  • Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
  • The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.
  • Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
  • It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
  • The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc.

Jenburkt Pharmaceuticals Ltd News Hub

News

Jenburkt Pharmaceuticals to declare Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

19 Jul 202410:24

News

Jenburkt Pharmaceuticals to conduct AGM

Jenburkt Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the compa...

Read more

24 Jun 202409:36

News

Board of Jenburkt Pharmaceuticals recommends final dividend

Jenburkt Pharmaceuticals announced that the Board of Directors of the Company at its meeti...

Read more

29 May 202410:57

News

Jenburkt Pharmaceuticals schedules board meeting

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2...

Read more

21 May 202415:36

News

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6...

Read more

20 Jan 202412:45

News

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7...

Read more

30 Oct 202314:04

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Jenburkt Pharmaceuticals Ltd

What is the market cap of Jenburkt Pharmaceuticals Ltd?

As of September 18, 2024, Jenburkt Pharmaceuticals Ltd has a market capitalization of ₹500.51, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Jenburkt Pharmaceuticals Ltd's market capitalization?

Jenburkt Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Jenburkt Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Jenburkt Pharmaceuticals Ltd's market capitalization change?

Jenburkt Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*